Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'
Eur Heart J
.
2018 Oct 1;39(37):3478.
doi: 10.1093/eurheartj/ehy406.
Authors
Denise Hilfiker-Kleiner
1
,
Karen Sliwa
2
,
Johann Bauersachs
1
Affiliations
1
Department of Cardiology and Angiology, MHH, Carl-Neuberg-Str. Hannover, Germany.
2
Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town, Private Bag X3, Observatory, Cape Town, South Africa.
PMID:
30016421
DOI:
10.1093/eurheartj/ehy406
No abstract available
Publication types
Comment
MeSH terms
Bromocriptine
Cardiomyopathies*
Denmark
Female
Humans
Peripartum Period
Puerperal Disorders*
Substances
Bromocriptine